tiprankstipranks
Neuren Pharmaceuticals Limited (NURPF)
OTHER OTC:NURPF
US Market
NURPF
Neuren Pharmaceuticals Limited
RESEARCH TOOLSreports
Want to see NURPF full AI Analyst Report?

Neuren Pharmaceuticals Limited (NURPF) Financial Statements

55 Followers

Neuren Pharmaceuticals Limited Financial Overview

Neuren Pharmaceuticals Limited's market cap is currently $1.14B. The company's EPS TTM is $0.0830484; its P/E ratio is 78.41; Neuren Pharmaceuticals Limited is scheduled to report earnings on February 26, 2026, and the estimated EPS forecast is $0.05. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 64.63MAU$ 213.24MAU$ 231.93MAU$ 14.55MAU$ 3.20M
Gross ProfitAU$ 64.61MAU$ 213.22MAU$ 205.17MAU$ 14.54MAU$ 3.19M
Operating IncomeAU$ 22.02MAU$ 175.55MAU$ 172.49MAU$ -1.60MAU$ -11.43M
EBITDAAU$ 22.05MAU$ 175.57MAU$ 199.26MAU$ -670.00KAU$ -10.98M
Net IncomeAU$ 30.44MAU$ 142.04MAU$ 157.08MAU$ 184.00KAU$ -7.79M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 296.12MAU$ 222.24MAU$ 228.54MAU$ 40.18MAU$ 36.78M
Total AssetsAU$ 342.86MAU$ 409.71MAU$ 247.97MAU$ 43.27MAU$ 40.06M
Total DebtAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -4.23MAU$ -3.15MAU$ -17.09MAU$ -40.18MAU$ -36.78M
Total LiabilitiesAU$ 4.41MAU$ 45.80MAU$ 42.76MAU$ 1.68MAU$ 803.00K
Stockholders' EquityAU$ 338.45MAU$ 363.90MAU$ 205.21MAU$ 41.59MAU$ 39.25M
Cash Flow
Free Cash FlowAU$ 125.39MAU$ -11.28MAU$ 184.88MAU$ 3.58MAU$ -9.98M
Operating Cash FlowAU$ 125.42MAU$ -11.27MAU$ 184.93MAU$ 3.60MAU$ -9.97M
Investing Cash FlowAU$ -88.01MAU$ 4.13MAU$ -211.49MAU$ -19.00KAU$ -10.00K
Financing Cash FlowAU$ -33.22MAU$ -8.78MAU$ 3.62MAU$ -2.00KAU$ 22.18M
Currency in AUD

Neuren Pharmaceuticals Limited Earnings and Revenue History

Income Statement >

Neuren Pharmaceuticals Limited Debt to Assets

Balance Sheet >

Neuren Pharmaceuticals Limited Cash Flow

Cash Flow >

Neuren Pharmaceuticals Limited Forecast EPS vs Actual EPS

Earnings >